← Evidence map

ArticlePloS one2023

Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.

Ravi K Anchoori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37315065